Literature DB >> 12137829

Feedback microwave thermotherapy versus TURP for clinical BPH--a randomized controlled multicenter study.

Lennart Wagrell1, Sonny Schelin, Jorgen Nordling, Jonas Richthoff, Bo Magnusson, Moddy Schain, Thayne Larson, Emmett Boyle, Jens Duelund, Kurt Kroyer, Håkan Ageheim, Anders Mattiasson.   

Abstract

OBJECTIVES: To compare the outcome of a microwave thermotherapy feedback system that is based on intraprostatic temperature measurement during treatment (ProstaLund Feedback Treatment or PLFT) with transurethral resection of the prostate (TURP) for clinical benign prostatic hyperplasia (BPH) in a randomized controlled multicenter study. The safety of the two methods was also investigated.
METHODS: The study was performed at 10 centers in Scandinavia and the United States. A total of 154 patients with clinical BPH were randomized to PLFT or TURP (ratio 2:1); 133 of them completed the study and were evaluated at the end of the study 12 months after treatment. Outcome measures included the International Prostate Symptom Score (IPSS), urinary flow, detrusor pressure at maximal urinary flow (Qmax), prostate volume, and adverse events. Patients were seen at 3, 6, and 12 months. Responders were defined according to a combination of IPSS and Qmax: IPSS 7 or less, or a minimal 50% gain, and/or Qmax 15 mL/s or greater or a minimal 50% gain.
RESULTS: No significant differences in outcome at 12 months were found between PLFT and TURP for IPSS, Qmax, or detrusor pressure. The prostate volume measured with transrectal ultrasonography was reduced by 30% after PLFT and 51% after TURP. Serious adverse events related to the given treatment were reported in 2% after PLFT and in 17% after TURP. Mild and moderate adverse events were more common in the PLFT group. With the criteria mentioned above, 82% and 86% of the patients were characterized as responders after 12 months in the PLFT and TURP groups, respectively. The post-treatment catheter time was 3 days in the TURP group and 14 days in the PLFT group.
CONCLUSIONS: The outcome of microwave thermotherapy with intraprostatic temperature monitoring was comparable with that seen after TURP in this study. From both a simplicity and safety point of view, PLFT appears to have an advantage. Taken together, our findings make us conclude that within a 1-year perspective microwave thermotherapy with PLFT is an attractive alternative to TURP in the treatment of BPH.

Entities:  

Mesh:

Year:  2002        PMID: 12137829     DOI: 10.1016/s0090-4295(02)01740-5

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  11 in total

1.  [S2e guideline of the German urologists: Instrumental treatment of benign prostatic hyperplasia].

Authors:  T Bschleipfer; T Bach; R Berges; K Dreikorn; C Gratzke; S Madersbacher; M-S Michel; R Muschter; M Oelke; O Reich; C Tschuschke; K Höfner
Journal:  Urologe A       Date:  2016-02       Impact factor: 0.639

Review 2.  Transurethral microwave thermotherapy for the treatment of BPH: still a challenger?

Authors:  T R W Herrmann; A J Gross; D Schultheiss; P M Kaufmann; U Jonas; M Burchardt
Journal:  World J Urol       Date:  2006-06-03       Impact factor: 4.226

3.  Energy delivery systems for treatment of benign prostatic hyperplasia: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2006-08-01

Review 4.  ProstaLund feedback thermotherapy: a review.

Authors:  Benjamin T Larson; Magnus B Bolmsjö; Lennart Wagrell; Thayne R Larson
Journal:  Curr Urol Rep       Date:  2003-08       Impact factor: 2.862

Review 5.  How do transurethral needle ablation of the prostate and transurethral microwave thermotherapy compare with transurethral prostatectomy?

Authors:  Ricardo R Gonzalez; Alexis E Te
Journal:  Curr Urol Rep       Date:  2003-08       Impact factor: 2.862

6.  Is the minimally invasive treatment as good as transurethral resection for benign prostatic hyperplasia?

Authors:  Emerson Luís Zani; Nelson Rodrigues Netto
Journal:  Int Urol Nephrol       Date:  2007-03-02       Impact factor: 2.266

Review 7.  Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network meta-analysis.

Authors:  Juan Va Franco; Jae Hung Jung; Mari Imamura; Michael Borofsky; Muhammad Imran Omar; Camila Micaela Escobar Liquitay; Shamar Young; Jafar Golzarian; Areti Angeliki Veroniki; Luis Garegnani; Philipp Dahm
Journal:  Cochrane Database Syst Rev       Date:  2021-07-15

8.  Transurethral Microwave Thermotherapy for Benign Prostatic Hyperplasia: An Updated Cochrane Review.

Authors:  Juan Victor Ariel Franco; Luis Garegnani; Camila Micaela Escobar Liquitay; Michael Borofsky; Philipp Dahm
Journal:  World J Mens Health       Date:  2021-08-04       Impact factor: 5.400

Review 9.  Long-term treatment outcomes of CoreTherm microwave feedback thermotherapy.

Authors:  Evan R Eisenberg; Gopal H Badlani
Journal:  Curr Urol Rep       Date:  2004-08       Impact factor: 2.862

10.  Transurethral microwave thermotherapy for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.

Authors:  Juan Va Franco; Luis Garegnani; Camila Micaela Escobar Liquitay; Michael Borofsky; Philipp Dahm
Journal:  Cochrane Database Syst Rev       Date:  2021-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.